Image
SumanSpeaks Capital Markets & Geopolitical Intelligence  ·  Estd 2006   Insolvency Law · Corporate Accountability When the Law Works Exactly as Designed — And Still Feels Wrong ₹22,006 crore in personal guarantees. Settled for ₹6.5 crore. Approved 80.81% to a minority that included two public sector banks — with the tribunal's own bench divided before a tie-breaking member stepped in. Subhash Chandra (Goenka), founder of the Essel Group and promoter emeritus of Zee, has settled a personal guarantee liability of ₹22,006 crore for ₹6.5 crore. The National Company Law Tribunal approved the plan this week. The case began small. In 2022, Indiabulls Housing Finance — now Sammaan Capital — moved against Chandra over a personal guarantee on a ₹170 crore loan to Vivek Infracon. By the time the insolvency plea was admitted in 2024, admitted c...
Tit - bits
#The BSE Sensex is now seen at 41,425.75 or
Photo: Seeking Alpha 
down just 99.75  points (-0.25%) while NSE's Nifty is trading at 12,196.55 or down only 25.40 points (-0.23%). This is much improvement from the level when the Sensex nosedived 200 - points. 
Market sentiment was affected by the fact that  International Monetary Fund (IMF) loweried India's growth forecast, apart from subdued quarterly results by key index constituents and negative global cues.
However,  what the market missed is that IMF on 20 January also said global growth, estimated at 2.9% in 2019, is projected to increase to 3.3% in 2020 and inch up further to 3.4% in 2021 -- which means growth would continue though a tad below the estimates. This is positive for the BULLS. 
For India too,  the outlook looks much better in CY2020 than for FY20, as per the IMF commentary, which said: India's growth is estimated at 4.8% in 2019, projected to improve to 5.8% in 2020 and 6.5% in 2021 (1.2% and 0.9% lower than the October forecast), supported by monetary and fiscal stimulus as well as subdued oil prices. 
Therefore, I feel the investors should use every opportunity to buy good stocks in situations like today,  to reap superb benefits in the short to medium term.

#Buy the shares of Strides Parma Science Ltd at the CMP of Rs.390.40, for short term targets of Rs. 415/417. SL: Rs.382.
The company recently announced successful closure of the US drug regulator's inspection at its manufacturing site in Florida, United States.

Comments

Popular posts from this blog